Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 2004

View Archived Issues

Caspases involved in immune thrombocytopenia

A triple TCR peptide vaccine shows promise in patients with multiple sclerosis

Novel CDK inhibitors from BMS show in vivo anticancer activity

Prous Science announces publication of a comprehensive review on insomnia

Shipment of Xifaxan under way

Conditional expansion of Sepracor and Aventis eszopiclone agreement

Nuvelo closes phase II alfimeprase study early

Spheramine granted fast track status for advanced Parkinson's disease

Potent glycogen synthase kinase-3beta inhibitors effective in vivo

Anti-CCR5 monoclonal antibody PRO-140 controls HIV-1 replication in vivo

CCR5 antagonist with potent anti-HIV activity in vitro

Genistein induces apoptosis in HIV-infected cells in vitro

Combination treatment with olive oil extract effective against HIV

Amarin to acquire Laxdale

Rotigotine reduces RLS symptoms in phase IIb trial

Bayer extends support for study in prophylactic treatment of hemophilia A

Cellegy and Strakan enter European commercialization agreement for Tostrex

EnVivo and MethylGene to develop isotypic HDAC inhibitors

PTC-124 enters phase I for cystic fibrosis and Duchenne muscular dystrophy

Initiation of final pivotal phase III study of doripenem for VAP

CLIA waiver for Uni-Gold Recombigen HIV test

Posaconazole NDA accepted for review

Phenomix and Genentech establish collaboration for immune disorders

Inhibitors of kinases claimed by Schering AG

Indolyl derivatives claimed by Roche

Silicon compounds for the treatment of cancer reported by Amedis

Active Biotech describes CD80 antagonists

Selective COX-2 inhibitors described by researchers at CJ Corporation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...